|
Volumn 23, Issue 2, 2008, Pages 421-426
|
Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation
|
Author keywords
Androgen; Controlled ovarian stimulation; Follicle growth; Recombinant human LH
|
Indexed keywords
ANDROGEN;
ESTRADIOL;
FOLLITROPIN;
HYDROXYPROGESTERONE;
LUTEINIZING HORMONE;
MUELLERIAN INHIBITING FACTOR;
RECOMBINANT CHORIONIC GONADOTROPIN;
RECOMBINANT FOLLITROPIN;
RECOMBINANT LUTEINIZING HORMONE;
TESTOSTERONE;
TRIPTORELIN;
RECOMBINANT PROTEIN;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOWN REGULATION;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG EFFECT;
DRUG MEGADOSE;
ECHOGRAPHY;
EMBRYO;
EMBRYO TRANSFER;
FEMALE;
FEMALE INFERTILITY;
FERTILIZATION;
HORMONE ACTION;
HORMONE BLOOD LEVEL;
HORMONE DETERMINATION;
HUMAN;
MAJOR CLINICAL STUDY;
METABOLISM;
MULTICENTER STUDY;
OOCYTE MATURATION;
OVARY FOLLICLE DEVELOPMENT;
OVARY FOLLICLE MATURATION;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL SIGNIFICANCE;
TREATMENT DURATION;
TREATMENT RESPONSE;
UPREGULATION;
DRUG ADMINISTRATION;
EMBRYO (ANATOMY);
FERTILIZATION IN VITRO;
OVARY FOLLICLE;
PHYSIOLOGY;
TREATMENT OUTCOME;
ADULT;
ANTI-MULLERIAN HORMONE;
DRUG ADMINISTRATION SCHEDULE;
EMBRYO, MAMMALIAN;
FEMALE;
FERTILIZATION;
FERTILIZATION IN VITRO;
FOLLICLE STIMULATING HORMONE, HUMAN;
HUMANS;
LUTEINIZING HORMONE;
OVARIAN FOLLICLE;
RECOMBINANT PROTEINS;
TREATMENT OUTCOME;
|
EID: 40349089757
PISSN: 02681161
EISSN: 14602350
Source Type: Journal
DOI: 10.1093/humrep/dem388 Document Type: Article |
Times cited : (80)
|
References (19)
|